These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 3491614)
1. Binding of a synthetic analogue of mitogenic bacterial lipoprotein to murine major histocompatibility complex (MHC) gene products. Scheuer WV; Biesert L; Bessler WG Biol Chem Hoppe Seyler; 1986 Oct; 367(10):1085-94. PubMed ID: 3491614 [TBL] [Abstract][Full Text] [Related]
2. Interaction of mitogenic bacterial lipoprotein and a synthetic analogue with mouse lymphocytes. Isolation and characterization of binding proteins. Biesert L; Scheuer W; Bessler WG Eur J Biochem; 1987 Feb; 162(3):651-7. PubMed ID: 3549292 [TBL] [Abstract][Full Text] [Related]
3. Mitogenic activities of synthetic Escherichia coli lipid A and a synthetic partial structure (tripalmitoyl pentapeptide) of E. coli lipoprotein. Brade L; Bessler WG; Brade H Infect Immun; 1988 May; 56(5):1382-4. PubMed ID: 3281910 [TBL] [Abstract][Full Text] [Related]
4. Synthetic analogues of the N-terminal lipid part of bacterial lipoprotein are B-lymphocyte mitogens in vitro and in vivo. Johnson RB; Köhl S; Wiesmüller K; Jung G; Bessler WG Immunobiology; 1983 Jul; 165(1):27-35. PubMed ID: 6350164 [TBL] [Abstract][Full Text] [Related]
5. A synthetic analogue of Escherichia coli lipoprotein, tripalmitoyl pentapeptide, constitutes a potent immune adjuvant. Lex A; Wiesmüller KH; Jung G; Bessler WG J Immunol; 1986 Oct; 137(8):2676-81. PubMed ID: 3531339 [TBL] [Abstract][Full Text] [Related]
6. Synthetic lipopeptide analogs of bacterial lipoprotein are potent polyclonal activators for murine B lymphocytes. Bessler WG; Cox M; Lex A; Suhr B; Wiesmüller KH; Jung G J Immunol; 1985 Sep; 135(3):1900-5. PubMed ID: 3874908 [TBL] [Abstract][Full Text] [Related]
7. The mitogenic principle of Escherichia coli lipoprotein: B-lymphocyte mitogenicity of the synthetic analogue palmitoyl-tetrapeptide (Pam-Ser-Ser-Asn-Ala). Bessler WG; Cox M; Wiesmüller KH; Jung G Biochem Biophys Res Commun; 1984 May; 121(1):55-61. PubMed ID: 6375670 [TBL] [Abstract][Full Text] [Related]
8. Lipopeptides of the N-terminus of Escherichia coli lipoprotein: synthesis, mitogenicity and properties in monolayer experiments. Prass W; Ringsdorf H; Bessler W; Wiesmüller KH; Jung G Biochim Biophys Acta; 1987 Jun; 900(1):116-28. PubMed ID: 3297144 [TBL] [Abstract][Full Text] [Related]
9. Polyclonal B-cell activation by a synthetic analogue of bacterial lipoprotein is functionally different from activation by bacterial lipopolysaccharide. Kleine B; Sprenger R; Martinez-Alonso C; Bessler WG Immunology; 1987 May; 61(1):29-34. PubMed ID: 3495485 [TBL] [Abstract][Full Text] [Related]
10. B-lymphocyte mitogenicity in vitro of a synthetic lipopeptide fragment derived from bacterial lipoprotein. Bessler WG; Johnson RB; Wiesmüller K; Jung G Hoppe Seylers Z Physiol Chem; 1982 Jul; 363(7):767-70. PubMed ID: 6751983 [TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of membrane receptors for pokeweed mitogens from mouse lymphocytes. Yokoyama K; Terao T; Osawa T Biochem J; 1977 Sep; 165(3):431-7. PubMed ID: 303517 [TBL] [Abstract][Full Text] [Related]
12. Polyclonal activation of B-lymphocytes in vivo by Salmonella typhimurium lipoprotein. Johnson RB; Köhl S; Bessler WG Infect Immun; 1983 Mar; 39(3):1481-4. PubMed ID: 6341238 [TBL] [Abstract][Full Text] [Related]
13. Protein I and protein II from the outer membrane of Escherichia coli are mouse B-lymphocyte mitogens. Bessler WG; Henning U Z Immunitatsforsch Immunobiol; 1979 Jun; 155(5):387-98. PubMed ID: 382663 [TBL] [Abstract][Full Text] [Related]
14. Induction of lymphocyte proliferation and membrane changes by lipopeptide derivatives of the lipoprotein from the outer membrane of Escherichia coli. Bessler W; Resch K; Hancock E; Hantke K Z Immunitatsforsch Immunobiol; 1977 Apr; 153(1):11-22. PubMed ID: 325934 [TBL] [Abstract][Full Text] [Related]
15. Murine IgA binding factors (IgA-BF) suppressing IgA production: characterization and target specificity of IgA-BF. Noro N; Adachi M; Yasuda K; Masuda T; Yodoi J J Immunol; 1986 Apr; 136(8):2910-6. PubMed ID: 3514749 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of T-cell responses to peptides and lipopeptides with MHC class I binding motifs derived from the amino acid sequence of the 19-kDa lipoprotein of Mycobacterium tuberculosis. Fonseca DP; Joosten D; Snippe H; Verheul AF Mol Immunol; 2000 Jun; 37(8):413-22. PubMed ID: 11090876 [TBL] [Abstract][Full Text] [Related]
17. LPS regulation of the immune response: separate mechanisms for murine B cell activation by lipid A (direct) and polysaccharide (macrophage-dependent) derived from Bacteroides LPS. Williamson SI; Wannemuehler MJ; Jirillo E; Pritchard DG; Michalek SM; McGhee JR J Immunol; 1984 Nov; 133(5):2294-300. PubMed ID: 6332842 [TBL] [Abstract][Full Text] [Related]
18. Synthetic lipopeptide immunomodulators derived from bacterial lipoprotein: tools for the standardization of in vitro assays. Bessler WG Dev Biol Stand; 1992; 77():49-56. PubMed ID: 1426672 [TBL] [Abstract][Full Text] [Related]
19. B cell mitogenic activity of house dust mite, Dermatophagoides farinae, antigens. Fujii S; Ono K; Shigeta S; Oka S; Jyo T; Yamashita U Immunol Lett; 1996 Jan; 49(1-2):37-42. PubMed ID: 8964607 [TBL] [Abstract][Full Text] [Related]
20. The lipoprotein of the outer membrane of Escherichia coli: a B-lymphocyte mitogen. Melchers F; Braun V; Galanos C J Exp Med; 1975 Aug; 142(2):473-82. PubMed ID: 1095681 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]